Unaligned News For The Dog Fancy ~ Since 2002
Columns: No Margins, No Limits, No Kidding!
Columns: No Margins, No Limits, No Kidding!
IMMUNIZE AGAINST THE IMPROBABLE?
The slogan is "Prevent The Preventable" so does that mean a new laboratory disease is about to be let loose?
October 2016 | TheDogPress.com
Barbara J. Andrews, Editor-In-Chief, SAAB
Canine infectious respiratory disease is not common but that doesn’t matter, it now has its own acronym – CIRD. Does that mean that canine adenovirus type 2 (CAV-2), canine parainfluenza, (CPiV) and disease caused by Bordetella bronchiseptica (Bb) is going to
become so common that it needs its own acronym-abbreviation?
Perhaps. See the veterinary marketing release below but first, a little
The first flu vaccine was introduced in 1938, the year I was born, but I don’t recall any “flu” when I was growing up. My children did not receive any flu vaccines and they only had typical colds. Perhaps we were living on some other planet because I don’t recall the Spanish Flu vaccine of 1955 either but flu.gov says there was a vaccine for it.
Thankfully, there was polio vaccine but childhood diseases back then were
measles, mumps, and chicken pox which we all caught and developed life-long immunity.
By the 60s we knew about “dog shots” when previous to that, hunting dogs got rabies shots but not much more. Somehow, they didn’t “catch” distemper and those other doggy diseases we are all paranoid about. Well, if you are old enough, you get the point.
If you are of the more gullible generation you will say “things have changed” and will smugly point out that there is more disease now. Yes. That IS my point.
So, doing my duty as editor of TheDogPress.com I will provide you with a 2005
example of medication marketing which we titled appropriately
Prescribing Death. That expose' was so powerful that the Health
Ranger used it to produce a
VIDEO with the same title. Read the following information presented
exactly as it was circulated to the veterinary community. Then take time
to visit the world's first
Vaccine Information Section
where our Veterinary consultants first told dog owners about Vaccine Induced
Disease (VID) and hope that dog owners will make a wise decision.
Introducing Vanguard® Rapid Resp Intranasal
This family of single-nostril (0.5 mL) respiratory vaccines helps protect dogs from key pathogens associated with
Canine Infectious Respiratory Disease (CIRD) and can make administration fast and comfortable.
For vaccination of healthy dogs 8 weeks of age or older as an aid in preventing respiratory disease caused by canine
adenovirus type 2 (CAV-2), canine parainfluenza caused by canine parainfluenza virus (CPiV) and disease caused by Bordetella bronchiseptica (Bb).
3 antigenic combinations:
• Bb + CPiV + CAV-2
• Bb + CPiV
• Bb only
Canine Infectious Respiratory Disease (CIRD)
Infectious respiratory disease in dogs can be caused by many different pathogens, both bacterial and viral. In most instances, the clinical signs will be identical regardless of the infecting
pathogen. Because co-infections frequently occur and may lead to more severe symptoms, a multivalent immunization protocol can help PREVENT THE
Efficacy and Safety Studies
Compared to controls:
• Reduced duration of Bordetella bronchiseptica nasal shedding (p<0.0001)
• Reduced cough post-challenge
No adverse events were reported in the
immediate post-vaccination period.
Abnormal health events or reactions reported in the late phase post-vaccination
period. (See table on the right)
1-Year Duration of Immunity9
VANGUARD® Rapid Resp Intranasal vaccines
have the 1st approved 1-year duration of immunity claim for the Bordetella
• Duration of coughing reduced 84.4% in
vaccinates as compared to controls (p<0.0001)
• Strong antibody response post-challenge
(days 370 to 398)
• Other respiratory clinical signs reduced
The use of intranasal and parenteral vaccines may help provide the best Bordetella bronchiseptica protection.10
• When the immune system is exposed to antigens from different routes, a faster and more robust immune response may be achieved
• Mucosal administration followed by systemic vaccination can help to avoid immune exclusion, specifically in seropositive patients11
BRONCHICINE® CAe – The Booster Shot™
All trademarks are the property of Zoetis Inc., its affiliates and/or its licensors. ©2016 Zoetis Inc. All rights reserved. February 2016. SAB-00290
Copyright © TheDogPress.com 1610
ii Dogma: 3-A -
click to share this article -
ii NetPlaces Network
"The Crud" jumped species barrier when UNF researched vaccine?
Pfizer shedding its animal health division after settling lawsuits.
Information reveals the dark side of the pharmaceutical industry.2
TheDogPlace.org for authoritative free DogCare information
If you breed or show dogs, get your news at TheDogPress.com
TheJudgesPlace.com especially for Judges, professional and owner handlers.